Pain and distress associated with peripheral IV access in children in emergency department.
Conditions
Interventions
Intervention 1: Intervention group 1: Intranasal ketamine administration, at a dose of 5 mg/kg from a 50 mg/cc ketamine ampule, produced by Rotexmedica, Germany, twenty minutes before peripheral intra
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 10 Years
Inclusion criteria
Inclusion criteria: 1 to 10 years-old Children Emergency department or wards admission Needing IV access for diagnostic and therapeutic interventions
Exclusion criteria
Exclusion criteria: Patients with critical or emergency conditions, or in other words, have level 1 triage and are treated in the resuscitation room All cases in which parents do not consent to sedation and analgesia prior to peripheral intravenous access All patients with a history of allergies to ketamine or midazolam Age less than one year or over 10 years Existence of serious underlying heart disease including heart failure, electrical heart disorders, congenital heart defects Presence of advanced liver or kidney disease, including renal failure or dialysis, history of kidney or liver transplantation, congenital metabolic disorders Children with cerebral palsy, cystic fibrosis and epilepsy Congenital or acquired jaw and facial abnormalities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Observational Scale Of Behavioral distress-Revised Score. Timepoint: 20 min after intervention. Method of measurement: Observational Scale Of Behavioral distress-Revised (OSBD-R).;Success rate of accessing peripheral Intravenous line. Timepoint: 20 min after the intervention. Method of measurement: Researcher observation based on the presence or lack of physical restraint during the procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate. Timepoint: 10 and 20 minutes after the intervention. Method of measurement: Portable Pulse Oximeter.;Oxygen Saturation. Timepoint: 10 and 20 minutes after the intervention. Method of measurement: Portable Pulse Oximeter.;Satisfaction of parents. Timepoint: Once after the end of the procedure. Method of measurement: 5 point likert scale.;Satisfaction of nurses. Timepoint: Once after the end of the procedure. Method of measurement: 5 point likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactIman Mehrabi
Iran University of Medical Sciences
Outcome results
None listed